Anzeige
Mehr »
Login
Freitag, 13.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Der zukünftige Solana-ETF, unterstützt von BlackRock, Fidelity & dem Rest der Wall Street!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 27.09.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
27.09.DORÉ COPPER MINING CORP: Doré Copper Announces Closing of $4.676 Million Non-Brokered Private Placement of Common Shares and Flow-Through Shares219Not for distribution to United States news wire services or for dissemination in the United States TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Doré Copper Mining Corp. (the "Corporation" or "Doré...
► Artikel lesen
27.09.LakeShore Biopharma Co., Ltd.: LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation136GAITHERSBURG, Md., Sept. 27, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering...
► Artikel lesen
27.09.Primo Water Corporation: Primo Water and Bluetriton Brands Announce Receipt of All Regulatory Approvals In Connection With Their All-Stock Combination62TAMPA, Fla. and STAMFORD, Conn., Sept. 27, 2024 /CNW/ - Primo Water Corporation (NYSE: PRMW) (TSX: PRMW) ("Primo Water") and an affiliate of BlueTriton Brands, Inc. ("BlueTriton") today announced...
► Artikel lesen
27.09.American Rebel Holdings Inc: American Rebel Announces 1-for-9 Reverse Stock Split40Nashville, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) - America's Patriotic Brand (the "Company"), today announced that it will effect a reverse stock split...
► Artikel lesen
27.09.Finanzminister Simsek traf sich in New York mit US-Rating-Agenturen-
27.09.Neuer Rekord bei den Zentralbankreserven-
27.09.Neue Drohnen-Modelle aus der Türkei für den internationalen Markt3
27.09.MRM: SCOR, MRM's reference shareholder, announced its intent to acquire all the remaining shares of MRM through a simplified public tender offer followed, if conditions are met, by a squeeze-out292Press release SCOR, MRM's reference shareholder, announced its intent to acquire all the remaining shares of MRM through a simplified public tender offer followed, if conditions are met, by...
► Artikel lesen
27.09.CMC Metals Ltd. Announces Clarifying News Release317VANCOUVER, British Columbia, Sept. 27, 2024 (GLOBE NEWSWIRE) -- CMC Metals Ltd. (TSX-V: CMB) (Frankfurt:ZM5P) ("CMC" or the "Company") announces that the TSX Venture Exchange (the "TSXV") has approved...
► Artikel lesen
27.09.Arqit announces leadership transition with the appointment of a new Chief Executive Officer261LONDON, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW), a leading provider of quantum-safe encryption, today announced a leadership transition. Andy Leaver, a seasoned...
► Artikel lesen
27.09.Legend Biotech USA Inc.: CARVYKTI is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line127Landmark CARTITUDE-4 study results show CARVYKTI® reduced the risk of death by 45 percent after three-year follow-upLate-breaking data featured in an oral presentation at the 21st International Myeloma...
► Artikel lesen
27.09.Global Mofy AI Limited Announces Receipt of Notification from Nasdaq756BEIJING, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the "Company" or "Global Mofy") (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production...
► Artikel lesen
27.09.PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)186DELRAY BEACH, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), today announced that on September 27, 2024, PetMeds granted...
► Artikel lesen
27.09.Devon Energy Corporation: Devon Energy Completes Strategic Acquisition in the Williston Basin478OKLAHOMA CITY, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today announced that it has completed its previously announced acquisition of Grayson Mill Energy, for a transaction...
► Artikel lesen
27.09.Espey Mfg. & Electronics Corp. reports fourth quarter and year-end results177SARATOGA SPRINGS, N.Y., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Espey Mfg. & Electronics Corp. (NYSE American: ESP) announces results for its fourth quarter and fiscal year, ended June 30, 2024. For the...
► Artikel lesen
27.09.Clover Leaf Capital Corp. Announces Adjournment of Special Meeting of Stockholders on Proposed Business Combination142MIAMI, FL and KANSAS CITY, KS, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Clover Leaf Capital Corp. (Nasdaq: CLOE) ("CLOE" or "Clover Leaf"), a publicly traded special purpose acquisition company, and Digital...
► Artikel lesen
27.09.Aimfinity Investment Corp. I Announces Extension of the Deadline for an Initial Business Combination to October 28, 2024127Wilmington, Delaware, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the "Company" or "AIMA") (Nasdaq: AIMAU), a special purpose acquisition company incorporated as a Cayman Islands...
► Artikel lesen
27.09.AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer102- Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression. - Biologics License...
► Artikel lesen
27.09.TransMedics Group, Inc.: TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)107ANDOVER, Mass., Sept. 27, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
► Artikel lesen
27.09.Poseida Therapeutics, Inc.: Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients123Data showed a 91% ORR with P-BCMA-ALLO1 in an optimized lymphodepletion arm, including a 100% ORR in BCMA-naïve patients, and an 86% ORR in those who had received at least one prior BCMA- and/or GPRC5D-targeting...
► Artikel lesen
Seite:  Weiter >>